BioAtla BCAB
OTC BCAB
$1.80 -0.01 (-0.55%)
At close: Nov 10, 2026 · 4:00 PM EST

BioAtla (BCAB) Operating Leases (2021 - 2026)

Updated

Analysis

BioAtla (BCAB) Operating Leases (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 BioAtla 2.99 Mn -15.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.29 Mn
Mar 31, 2026 4.54 Mn
Dec 31, 2025 4.77 Mn
Sep 30, 2025 5.01 Mn
Jun 30, 2025 5.24 Mn
Mar 31, 2025 554,000.00
Mar 31, 2024 415,000.00
Dec 31, 2023 836,000.00
Sep 30, 2023 1.25 Mn
Jun 30, 2023 1.66 Mn
Mar 31, 2023 2.06 Mn
Dec 31, 2022 2.46 Mn
Sep 30, 2022 2.85 Mn
Jun 30, 2022 3.23 Mn
Mar 31, 2022 3.61 Mn
Dec 31, 2021 3.98 Mn
API Access

BioAtla Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=BCAB&period=max&api_key=YOUR_API_KEY